During the 6 months prior to insulin pump therapy initiation, the mean HbA1c was 10.1±1.2%, the mean blood glucose level was 233±33.6 mg/dL and the mean frequency of hypoglycemic episodes per month was 2.9±0.9. The total numbers of hypoglycemic convulsive and DKA episodes were 2 and 7 episodes, respectively. Six months post-insulin therapy, the mean HbA1c was 7.3±0.5% (P=0.0002), the mean blood glucose level was 155±33.2 mg/dL (P=0.002) and the mean frequency of hypoglycemic episodes per month was 1.7±0.5 (P=0.002). There was no report of hypoglycemic convulsion or coma during CSII therapy. The treatment satisfaction score was 26.5 pre-insulin pump therapy and improved to a mean score of 34.3 post-insulin pump therapy (P<0.0001).
A tremendous amount of data has shown that intensive diabetes management with CSII is a durable and an effective means of optimizing glycemic control in pediatric patients and may improve their quality of life. 1 We showed that insulin pump therapy was effective in treating 9 Saudi type 1 diabetic children. Their parents were more satisfied with this modality of intensive insulin therapy compared with CI therapy. Intensified insulin therapy using external pumps provides users with flexibility in their eating schedule and an ability to correct high and low blood sugar readings by adjusting the insulin boluses and basal insulin infusion rate. In this trial, the rate of hyperglycemic and hypoglycemic episodes was less on CSII therapy. Meals were covered with the ultra shortacting insulin, which minimized postprandial hypo-and hyperglycemia. CSII therapy also fits into children's lifestyle and different daily activities. The basal infusion rate was reduced during exercise and some children were placed on a temporary basal rate during sports. Some parents felt that they gained more information on diabetes management and diet therapy during insulin pump therapy. Other children felt that they were able to predict blood glucose level based on what they ate. They were able to control blood glucose by calculating the appropriate correction for the insulin bolus dose. Some children reported that frequent checking of blood glucose was more enjoyable for them because they can easily correct high readings through the pump and without having an injection. In conclusion, CSII improved glycemic control in Saudi diabetic children and improved their quality of life. Parents of children on insulin pump therapy were more satisfied with this modality of intensive insulin treatment.
